A comparison of anti-CD20 chimeric antigen receptors in targeting B-cell malignancies

被引：0
|
作者：
Britton, R. [1 ]
French, R. [1 ]
Glennie, M. [1 ]
机构：
[1] Univ Southampton, Southampton, Hants, England
来源：
IMMUNOLOGY | 2013年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [31] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    Oyama, T
    Kagami, Y
    Seto, M
    Morishima, Y
    [J]. LEUKEMIA, 2001, 15 (10) : 1667 - 1667
  • [32] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    James N. Kochenderfer
    Steven A. Rosenberg
    [J]. Nature Reviews Clinical Oncology, 2013, 10 : 267 - 276
  • [33] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    Kochenderfer, James N.
    Rosenberg, Steven A.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (05) : 267 - 276
  • [34] Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
    R. O. Dillman
    [J]. Clinical and Experimental Medicine, 2006, 6
  • [35] Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma
    Dillman, RO
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3545 - 3557
  • [36] Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
    Dillman, RO
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2006, 6 (01) : 1 - 12
  • [37] Adoptive T-cell therapy of B-cell malignancies: Conventional and physiological chimeric antigen receptors
    Liu, Lin
    Sun, Meili
    Wang, Zhehai
    [J]. CANCER LETTERS, 2012, 316 (01) : 1 - 5
  • [38] UBLITUXIMAB (TG-1101), A NOVEL ANTI-CD20 MONOCLONAL FOR RITUXIMAB RELAPSED/REFRACTORY B-CELL MALIGNANCIES
    Deng, C.
    Amengual, J.
    Schreeder, M.
    Pauli, E.
    Cutter, K.
    Sportelli, P.
    Miskin, H.
    O'Connor, O.
    [J]. HAEMATOLOGICA, 2013, 98 : 139 - 139
  • [39] Subcutaneous injections of low doses of veltuzumab (humanized anti-CD20 antibody): Objective responses in B-cell malignancies
    Allen, S. L.
    Rai, K. R.
    Elstrom, R.
    Negrea, O. G.
    Farber, C. M.
    Abbasi, R.
    Teoh, N.
    Horne, H.
    Wegener, W. A.
    Goldenberg, D. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] UBLITUXIMAB (TG-1101), A NOVEL ANTI-CD20 MONOCLONAL FOR RITUXIMAB RELAPSED/REFRACTORY B-CELL MALIGNANCIES
    O'Connor, O. A.
    Schreeder, M. T.
    Deng, C.
    Amengual, J. E.
    Boccia, R.
    Khalil, M. Y.
    Mahadevan, D.
    Nikolinakos, P.
    Patterson, M.
    Pauli, E. K.
    Cutter, K.
    Mackenzie, M.
    DiSilvestre, C.
    Moon, A.
    Brotherton, M.
    Sportelli, P.
    Miskin, H. P.
    Farber, C. M.
    [J]. HAEMATOLOGICA, 2014, 99 : 142 - 143
12345